Use of Biopolymers in Mucosally-Administered Vaccinations for Respiratory Disease

Use of Biopolymers in Mucosally-Administered Vaccinations for Respiratory Disease

Communicable respiratory infections are the cause of a significant number of infectious diseases. The introduction of vaccinations has greatly improved this situation. Moreover, adjuvants have allowed for vaccines to be more effective with fewer adverse side effects. However, there is still space fo...

Full description

Bibliographic Details
Main Authors: Margaret R. Dedloff, Callie S. Effler, Alina Maria Holban, Monica C. Gestal
Format: Article
Language:English
Published: MDPI AG 2019-07-01
Series:Materials
Subjects:
polymeric vaccines
respiratory infections
mucosal administration
immunomodulation
nanovaccines
Online Access:https://www.mdpi.com/1996-1944/12/15/2445

Internet

https://www.mdpi.com/1996-1944/12/15/2445

Similar Items